Conference Chair
Michael Graner Associate Professor, University of Colorado Anschutz School of Medicine |
 Keynote Speakers
OverviewSelectBIO Extracellular Vesicles and Stem Cells 2020 Summit brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles Produced by Stem Cells and their Functional Activities
- Exosome/EV Engineering
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development and Regenerative Medicine
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date based on research involving stem cells and stem cell-derived extracellular vesicles (EVs) for clinical utility and regenerative medicine.
Information and Local Registration Facilities for this Conference are Also Available In:
Japanese
|
Korean
|
Chinese (Simplified)
|
Chinese (Traditional)
Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 31 January 2020 Agenda Topics- Engineering EVs as Biologic Drugs
- Engineering Exosomes and Extracellular Vesicles (EVs)
- Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
- Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy and Intersection with the Extracellular Vesicles (EV) Axis
- Stem Cell-based EVs for Regenerative Medicine
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateJohnathon Anderson, Assistant Professor, University of California Davis Health Chaya Brodie, Professor, Henry Ford Hospital John Ludlow, Executive Director, Regenerative Medicine, Zen-Bio, Inc. My Mahoney, Professor and Vice Chair, Thomas Jefferson University
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|